124 related articles for article (PubMed ID: 10815760)
1. Characterization of steroid hormone sensitivity in human breast cancers maintained ex vivo under organotypical culture conditions.
Darro F; Schwarz G; Pétein M; Schwarz S; Chaboteaux C; Nogaret JM; Decaestecker C; Salmon I; Kiss R
J Cancer Res Clin Oncol; 2000 May; 126(5):257-62. PubMed ID: 10815760
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
3. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
[TBL] [Abstract][Full Text] [Related]
4. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
Layfield LJ; Saria EA; Conlon DH; Kerns BJ
J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo.
Bhattacharya D; Redkar A; Mittra I; Sutaria U; MacRae KD
Br J Cancer; 1997; 75(4):554-8. PubMed ID: 9052410
[TBL] [Abstract][Full Text] [Related]
8. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
9. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative determination with image analysis of immunohistochemically identified steroid hormone receptors in breast carcinoma].
Mink D; Uhrmacher S; Heiss C; Villena-Heinsen C; Schmidt W
Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):17-22. PubMed ID: 7705593
[TBL] [Abstract][Full Text] [Related]
11. The impact of progesterone on simultaneous, local secretion of IGFBP-3 and IGF-I [IGFBP-3/IGF-I index] by human malignant and non-malignant breast explants depends on tissue steroid receptor phenotype.
Krzysiek J; Milewicz T; Augustowska K; Sztefko K; Ryś J; Zubel A; Pityński K; Jaszczyński P; Herman K; Basta A; Stachura J; Gregoraszczuk EŁ
Ginekol Pol; 2003 Sep; 74(9):767-74. PubMed ID: 14674122
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
Pichon MF; Milgrom E
Br J Cancer; 1992 Jun; 65(6):895-7. PubMed ID: 1616860
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
Saez S; Martin PM; Chouvet CD
Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies of canine mammary tumors: influence of 17-beta-estradiol and progesterone on cell kinetics parameters.
Lespagnard L; Kiss R; Danguy A; Legros N; Lenglet G; Devleeschouwer N; Paridaens R
Oncology; 1987; 44(5):292-301. PubMed ID: 3670796
[TBL] [Abstract][Full Text] [Related]
15. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
Kunc M; Biernat W; Senkus-Konefka E
Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
[TBL] [Abstract][Full Text] [Related]
17. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
18. In vitro influence of estradiol or progesterone on the thymidine labeling indices of human benign breast tumors.
Coibion M; Kiss R; Jossa V; de Launoit Y; Van Geloven O; Malengreau A; Mattheiem W; Pasteels JL; Paridaens R
Anticancer Res; 1989; 9(2):475-82. PubMed ID: 2751271
[TBL] [Abstract][Full Text] [Related]
19. [Expression of oestrogen receptor-beta in invasive breast tumours].
Péter I; Számel I; Péley G
Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
[TBL] [Abstract][Full Text] [Related]
20. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
